Moscow, September 02, 2016
PJSC Pharmstandard (LSE: PHST IL, МОЕХ: PHST RU) (hereinafter the "Company" or "Pharmstandard") announces the receipt of notification on expiration of mandatory tender offer (the "Notification").
On September 02, 2016 the Company received from Augment Investments Limited, its controlling shareholder, the Notification on expiration of Russian law governed mandatory tender offer (the "Offer") to acquire for cash ordinary shares of the Company from the remaining shareholders at a purchase price of RUB 1,028 per ordinary share.
The Notification confirms that during the Offer Augment Investments Limited received applications from remaining shareholders to sell 4 538 684 ordinary shares.
In accordance to the Offer terms, the applicants have to enroll ordinary shares stated in the applications to the account of Augment Investments Limited within 15 days from the day of expiration of the Offer.
This information is provided by RNS